Cerus (CERS) Stock Forecast, Price Target & Predictions
CERS Stock Forecast
Cerus stock forecast is as follows: an average price target of $4.50 (represents a 122.77% upside from CERS’s last price of $2.02) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
CERS Price Target
The average price target for Cerus (CERS) is $4.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $5.00 to $4.00. This represents a potential 122.77% upside from CERS's last price of $2.02.
CERS Analyst Ratings
According to 3 Wall Street analysts, Cerus's rating consensus is 'Buy'. The analyst rating breakdown for CERS stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Cerus Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 03, 2024 | Brandon Folkes | Cantor Fitzgerald | $4.00 | $1.76 | 127.27% | 98.02% |
| Apr 12, 2024 | Bill Bonello | Craig-Hallum | $5.00 | $1.79 | 179.33% | 147.52% |
The latest Cerus stock forecast, released on May 03, 2024 by Brandon Folkes from Cantor Fitzgerald, set a price target of $4.00, which represents a 127.27% increase from the stock price at the time of the forecast ($1.76), and a 98.02% increase from CERS last price ($2.02).
Cerus Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $4.50 |
| Last Closing Price | $2.02 | $2.02 | $2.02 |
| Upside/Downside | -100.00% | -100.00% | 122.77% |
In the current month, the average price target of Cerus stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Cerus's last price of $2.02. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 05, 2024 | BTIG | Neutral | Neutral | Hold |
| May 03, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
| Apr 12, 2024 | Craig-Hallum | - | Buy | Initialise |
Cerus's last stock rating was published by BTIG on Aug 05, 2024. The company gave CERS a "Neutral" rating, the same as its previous rate.
Cerus Financial Forecast
Cerus Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $46.77M | $39.77M | $38.85M | $30.97M | $44.03M | $39.57M | $41.00M | $37.44M | $50.09M | $42.10M | $37.76M | $29.57M | $33.59M | $29.19M | $26.83M | $24.64M | $26.49M | $22.85M |
| Avg Forecast | $60.62M | $59.06M | $57.43M | $55.05M | $58.75M | $55.99M | $55.10M | $48.29M | $53.08M | $49.90M | $47.63M | $43.23M | $53.57M | $48.73M | $47.65M | $38.40M | $49.16M | $46.83M | $46.01M | $41.67M | $43.90M | $37.26M | $31.40M | $27.54M | $28.20M | $28.60M | $25.89M | $22.80M | $25.30M | $22.60M |
| High Forecast | $61.39M | $59.81M | $58.16M | $55.75M | $59.50M | $56.70M | $55.79M | $48.90M | $53.75M | $50.53M | $48.23M | $43.77M | $54.24M | $49.35M | $48.26M | $38.89M | $49.79M | $47.42M | $46.30M | $41.94M | $44.18M | $37.50M | $31.60M | $27.71M | $28.38M | $28.79M | $26.05M | $22.95M | $25.46M | $22.74M |
| Low Forecast | $59.37M | $57.84M | $56.24M | $53.91M | $57.54M | $54.83M | $53.96M | $47.29M | $51.99M | $48.87M | $46.65M | $42.33M | $52.46M | $47.73M | $46.67M | $37.61M | $48.15M | $45.86M | $45.52M | $41.24M | $43.44M | $36.87M | $31.07M | $27.25M | $27.91M | $28.31M | $25.62M | $22.56M | $25.03M | $22.36M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 | 10 | 10 | 10 | 9 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.87% | 0.82% | 0.82% | 0.81% | 0.90% | 0.84% | 0.89% | 0.90% | 1.14% | 1.13% | 1.20% | 1.07% | 1.19% | 1.02% | 1.04% | 1.08% | 1.05% | 1.01% |
Cerus's average Quarter revenue forecast for Mar 24 based on 1 analysts is $43.23M, with a low forecast of $42.33M, and a high forecast of $43.77M. CERS's average Quarter revenue forecast represents a -7.57% decrease compared to the company's last Quarter revenue of $46.77M (Dec 23).
Cerus EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 | 10 | 10 | 10 | 9 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $976.00K | $-5.24M | $-11.64M | $-14.15M | $-9.95M | $-6.57M | $-6.10M | $-9.77M | $-6.90M | $-10.32M | $-13.17M | $-15.59M | $-12.53M | $-12.33M | $-13.09M | $-14.77M | $-15.26M | $-17.00M |
| Avg Forecast | $-29.75M | $-28.98M | $-28.18M | $-27.01M | $-28.83M | $-27.47M | $-27.04M | $-23.70M | $-26.05M | $-24.49M | $-23.37M | $-14.73M | $-26.29M | $-23.92M | $-23.39M | $-13.39M | $-24.13M | $-14.76M | $-22.58M | $-12.18M | $-21.54M | $-18.28M | $-15.41M | $-13.86M | $-13.84M | $-14.04M | $-12.70M | $-14.77M | $-12.41M | $-11.09M |
| High Forecast | $-29.13M | $-28.38M | $-27.60M | $-26.46M | $-28.24M | $-26.91M | $-26.48M | $-23.21M | $-25.51M | $-23.98M | $-22.89M | $-11.79M | $-25.74M | $-23.42M | $-22.90M | $-10.72M | $-23.63M | $-11.81M | $-22.34M | $-9.74M | $-21.32M | $-18.09M | $-15.25M | $-11.09M | $-13.69M | $-13.89M | $-12.57M | $-11.81M | $-12.28M | $-10.97M |
| Low Forecast | $-30.12M | $-29.35M | $-28.54M | $-27.36M | $-29.20M | $-27.82M | $-27.38M | $-24.00M | $-26.38M | $-24.80M | $-23.67M | $-17.68M | $-26.62M | $-24.22M | $-23.68M | $-16.07M | $-24.43M | $-17.71M | $-22.72M | $-14.61M | $-21.68M | $-18.40M | $-15.51M | $-16.63M | $-13.93M | $-14.13M | $-12.79M | $-17.72M | $-12.49M | $-11.16M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.04% | 0.22% | 0.50% | 1.06% | 0.41% | 0.45% | 0.27% | 0.80% | 0.32% | 0.56% | 0.85% | 1.13% | 0.91% | 0.88% | 1.03% | 1.00% | 1.23% | 1.53% |
1 analysts predict CERS's average Quarter EBITDA for Mar 24 to be $-14.73M, with a high of $-11.79M and a low of $-17.68M. This is -1609.65% lower than Cerus's previous annual EBITDA (Dec 23) of $976.00K.
Cerus Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 | 10 | 10 | 10 | 9 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-1.33M | $-7.27M | $-13.28M | $-15.64M | $-13.63M | $-8.52M | $-8.39M | $-12.28M | $-9.12M | $-12.44M | $-15.36M | $-17.46M | $-14.38M | $-14.14M | $-14.87M | $-16.47M | $-16.92M | $-17.97M |
| Avg Forecast | $3.70M | - | $-1.85M | $-3.70M | $-616.54K | $-2.47M | $-3.08M | $-8.02M | $-3.33M | $-5.92M | $-7.77M | $-18.17M | $-5.09M | $-9.87M | $-10.64M | $-16.52M | $-10.28M | $-17.78M | $-12.95M | $-15.01M | $-14.34M | $-17.57M | $-18.04M | $-15.52M | $-16.11M | $-18.50M | $-20.35M | $-16.47M | $-21.58M | $-22.20M |
| High Forecast | $3.76M | - | $-1.80M | $-3.60M | $-599.99K | $-2.40M | $-3.00M | $-7.80M | $-3.24M | $-5.76M | $-7.56M | $-14.53M | $-4.95M | $-9.60M | $-10.35M | $-13.21M | $-10.01M | $-14.23M | $-12.77M | $-12.01M | $-14.14M | $-17.33M | $-17.79M | $-12.41M | $-15.89M | $-18.25M | $-20.07M | $-13.17M | $-21.29M | $-21.90M |
| Low Forecast | $3.60M | - | $-1.88M | $-3.76M | $-626.69K | $-2.51M | $-3.13M | $-8.15M | $-3.38M | $-6.02M | $-7.90M | $-21.80M | $-5.17M | $-10.03M | $-10.81M | $-19.82M | $-10.45M | $-21.34M | $-13.06M | $-18.02M | $-14.46M | $-17.72M | $-18.19M | $-18.62M | $-16.24M | $-18.65M | $-20.52M | $-19.76M | $-21.76M | $-22.38M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.26% | 0.74% | 1.25% | 0.95% | 1.32% | 0.48% | 0.65% | 0.82% | 0.64% | 0.71% | 0.85% | 1.13% | 0.89% | 0.76% | 0.73% | 1.00% | 0.78% | 0.81% |
Cerus's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CERS's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Cerus SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 | 10 | 10 | 10 | 9 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $17.27M | $16.16M | $20.54M | $21.55M | $23.16M | $19.91M | $19.53M | $20.73M | $22.00M | $20.36M | $19.76M | $19.17M | $18.69M | $16.30M | $16.11M | $15.91M | $17.16M | $16.14M |
| Avg Forecast | $39.21M | $38.20M | $37.15M | $35.61M | $38.01M | $36.22M | $35.64M | $31.24M | $34.34M | $32.28M | $30.81M | $30.66M | $34.65M | $31.53M | $30.83M | $27.88M | $31.80M | $29.11M | $29.76M | $25.34M | $28.39M | $24.10M | $20.31M | $17.04M | $18.24M | $18.50M | $16.75M | $15.91M | $16.36M | $14.62M |
| High Forecast | $39.71M | $38.69M | $37.62M | $36.06M | $38.49M | $36.67M | $36.09M | $31.63M | $34.77M | $32.68M | $31.20M | $36.80M | $35.09M | $31.92M | $31.22M | $33.45M | $32.21M | $34.93M | $29.95M | $30.41M | $28.58M | $24.26M | $20.44M | $20.45M | $18.36M | $18.62M | $16.85M | $19.10M | $16.47M | $14.71M |
| Low Forecast | $38.40M | $37.41M | $36.38M | $34.87M | $37.22M | $35.47M | $34.90M | $30.59M | $33.63M | $31.61M | $30.18M | $24.53M | $33.93M | $30.87M | $30.19M | $22.30M | $31.15M | $23.29M | $29.45M | $20.27M | $28.10M | $23.85M | $20.10M | $13.63M | $18.05M | $18.31M | $16.57M | $12.73M | $16.19M | $14.47M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.50% | 0.51% | 0.67% | 0.77% | 0.73% | 0.68% | 0.66% | 0.82% | 0.77% | 0.84% | 0.97% | 1.13% | 1.02% | 0.88% | 0.96% | 1.00% | 1.05% | 1.10% |
Cerus's average Quarter SG&A projection for Mar 24 is $30.66M, based on 1 Wall Street analysts, with a range of $24.53M to $36.80M. The forecast indicates a 77.57% rise compared to CERS last annual SG&A of $17.27M (Dec 23).
Cerus EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 | 10 | 10 | 10 | 9 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.01 | $-0.04 | $-0.07 | $-0.09 | $-0.08 | $-0.05 | $-0.05 | $-0.07 | $-0.05 | $-0.07 | $-0.09 | $-0.10 | $-0.09 | $-0.08 | $-0.09 | $-0.10 | $-0.12 | $-0.13 |
| Avg Forecast | $0.02 | - | $-0.01 | $-0.02 | $-0.00 | $-0.01 | $-0.02 | $-0.04 | $-0.02 | $-0.03 | $-0.04 | $-0.05 | $-0.03 | $-0.05 | $-0.06 | $-0.08 | $-0.06 | $-0.06 | $-0.07 | $-0.08 | $-0.08 | $-0.10 | $-0.10 | $-0.10 | $-0.09 | $-0.10 | $-0.11 | $-0.11 | $-0.12 | $-0.12 |
| High Forecast | $0.02 | - | $-0.01 | $-0.02 | $-0.00 | $-0.01 | $-0.02 | $-0.04 | $-0.02 | $-0.03 | $-0.04 | $-0.05 | $-0.03 | $-0.05 | $-0.06 | $-0.08 | $-0.05 | $-0.06 | $-0.07 | $-0.08 | $-0.08 | $-0.09 | $-0.10 | $-0.10 | $-0.09 | $-0.10 | $-0.11 | $-0.11 | $-0.12 | $-0.12 |
| Low Forecast | $0.02 | - | $-0.01 | $-0.02 | $-0.00 | $-0.01 | $-0.02 | $-0.04 | $-0.02 | $-0.03 | $-0.04 | $-0.05 | $-0.03 | $-0.05 | $-0.06 | $-0.08 | $-0.06 | $-0.06 | $-0.07 | $-0.08 | $-0.08 | $-0.10 | $-0.10 | $-0.10 | $-0.09 | $-0.10 | $-0.11 | $-0.11 | $-0.12 | $-0.12 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.27% | 0.75% | 1.28% | 1.05% | 1.38% | 0.84% | 0.68% | 0.85% | 0.68% | 0.74% | 0.92% | 1.00% | 1.03% | 0.80% | 0.82% | 0.91% | 1.03% | 1.08% |
According to undefined Wall Street analysts, Cerus's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CERS previous annual EPS of $NaN (undefined).
Cerus Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CUTR | Cutera | $0.69 | $39.25 | 5588.41% | Hold |
| RPID | Rapid Micro Biosystems | $0.84 | $8.00 | 852.38% | Hold |
| ARAY | Accuray | $1.92 | $6.00 | 212.50% | Buy |
| CERS | Cerus | $2.02 | $4.50 | 122.77% | Buy |
| MXCT | MaxCyte | $3.79 | $8.00 | 111.08% | Buy |
| CVRX | CVRx | $8.42 | $16.20 | 92.40% | Buy |
| OFIX | Orthofix Medical | $16.24 | $31.00 | 90.89% | - |
| ESTA | Establishment Labs | $41.59 | $78.00 | 87.55% | Buy |
| NPCE | NeuroPace | $7.20 | $12.88 | 78.89% | Buy |
| LUNG | Pulmonx | $7.31 | $12.25 | 67.58% | Buy |
| SGHT | Sight Sciences | $6.35 | $10.33 | 62.68% | Hold |
| KIDS | OrthoPediatrics | $30.66 | $44.40 | 44.81% | Buy |
| CNMD | CONMED | $74.17 | $101.00 | 36.17% | Buy |
| SIBN | SI-BONE | $15.15 | $20.00 | 32.01% | Buy |
| BRKR | Bruker | $64.01 | $71.67 | 11.97% | Buy |
| SRDX | Surmodics | $38.83 | $39.50 | 1.73% | Buy |
| ITGR | Integer | $129.00 | $131.00 | 1.55% | Buy |
| BVS | Bioventus | $9.53 | $7.50 | -21.30% | Buy |
| GKOS | Glaukos | $129.28 | $101.56 | -21.44% | Buy |
CERS Forecast FAQ
Is Cerus a good buy?
Yes, according to 3 Wall Street analysts, Cerus (CERS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of CERS's total ratings.
What is CERS's price target?
Cerus (CERS) average price target is $4.5 with a range of $4 to $5, implying a 122.77% from its last price of $2.02. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Cerus stock go up soon?
According to Wall Street analysts' prediction for CERS stock, the company can go up by 122.77% (from the last price of $2.02 to the average price target of $4.5), up by 147.52% based on the highest stock price target, and up by 98.02% based on the lowest stock price target.
Can Cerus stock reach $3?
CERS's average twelve months analyst stock price target of $4.5 supports the claim that Cerus can reach $3 in the near future.
What are Cerus's analysts' financial forecasts?
Cerus's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $218.13M (high $220.89M, low $213.62M), average EBITDA is $-107M (high $-105M, low $-108M), average net income is $-14.182M (high $-13.801M, low $-14.415M), average SG&A $141.1M (high $142.88M, low $138.18M), and average EPS is $-0.0767 (high $-0.0746, low $-0.0779). CERS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $232.16M (high $235.1M, low $227.37M), average EBITDA is $-114M (high $-112M, low $-115M), average net income is $-1.85M (high $-1.64M, low $-2.04M), average SG&A $150.18M (high $152.08M, low $147.07M), and average EPS is $-0.01 (high $-0.00887, low $-0.011).
Did the CERS's actual financial results beat the analysts' financial forecasts?
Based on Cerus's last annual report (Dec 2023), the company's revenue was $156.4M, which missed the average analysts forecast of $188.36M by -16.97%. Apple's EBITDA was $156.4M, missing the average prediction of $-86.983M by -279.81%. The company's net income was $0, missing the average estimation of $-42.104M by -100.00%. Apple's SG&A was $0, missing the average forecast of $124.88M by -100.00%. Lastly, the company's EPS was $0, missing the average prediction of $-0.222 by -100.00%. In terms of the last quarterly report (Dec 2023), Cerus's revenue was $46.77M, missing the average analysts' forecast of $53.57M by -12.69%. The company's EBITDA was $976K, missing the average prediction of $-26.287M by -103.71%. Cerus's net income was $-1.328M, missing the average estimation of $-5.087M by -73.89%. The company's SG&A was $17.27M, missing the average forecast of $34.65M by -50.16%. Lastly, the company's EPS was $-0.0073, missing the average prediction of $-0.0275 by -73.45%